Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Immunity|June 11, 2022
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variantsMarios Koutsakos, Wen Shi Lee, Arnold Reynaldi, et al.Cell Reports. Medicine|May 17, 2021
Decay of Fc-dependent antibody functions after mild to moderate COVID-19Wen Shi Lee, Kevin John Selva, Samantha K Davis, et al.Science Advances|June 1, 2019
Defining early SIV replication and dissemination dynamics following vaginal transmissionClaire Deleage, Taina T Immonen, Christine M Fennessey, et al.JCI Insight|July 7, 2017
Fc functional antibodies in humans with severe H7N9 and seasonal influenzaHillary A Vanderven, Lu Liu, Fernanda Ana-Sosa-Batiz, et al.Journal of Virology|May 26, 2017
Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment InterruptionWen Shi Lee, Anne B Kristensen, Thomas A Rasmussen, et al.Plos Pathogens|May 5, 2017
Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapyChristine M Fennessey, Mykola Pinkevych, Taina T Immonen, et al.Science Immunology|February 9, 2024
Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adultsHelen R Wagstaffe, Ryan S Thwaites, Arnold Reynaldi, et al.Journal of Hepatology|April 11, 2024
B-cell characteristics define HCV reinfection outcomeAlexander P Underwood, Money Gupta, Bing-Ru Wu, et al.Science Advances|July 21, 2023
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infectionWen Shi Lee, Hyon-Xhi Tan, Arnold Reynaldi, et al.JCI Insight|September 22, 2023
Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infectionsKevin J Selva, Pradhipa Ramanathan, Ebene R Haycroft, et al.Pageof 6